Julio Enrique Serrano Noguès
Director/Miembro de la Junta en INBEST PRIME II INMUEBLES SOCIMI, S.A. .
Perfil
Julio Enrique Serrano Noguès is currently the Chief Executive Officer at Palbox Holding Sl and Director at Curapath & Expansion of Drug Delivery Capabilities & Services.
He is also a Director at Inbest Prime II Inmuebles SOCIMI SA and Inbest Prime III Inmuebles SOCIMI SA. Mr. Serrano Noguès completed his undergraduate degree at the University of Valencia.
Cargos activos de Julio Enrique Serrano Noguès
Empresas | Cargo | Inicio |
---|---|---|
INBEST PRIME II INMUEBLES SOCIMI, S.A. | Director/Miembro de la Junta | 13/05/2019 |
INBEST PRIME III INMUEBLES SOCIMI, S.A. | Director/Miembro de la Junta | 13/05/2019 |
Palbox Holding Sl | Director Ejecutivo | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Director/Miembro de la Junta | - |
Formación de Julio Enrique Serrano Noguès.
University of Valencia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
INBEST PRIME II INMUEBLES SOCIMI, S.A. | Finance |
INBEST PRIME III INMUEBLES SOCIMI, S.A. | Finance |
Empresas privadas | 2 |
---|---|
Palbox Holding Sl | |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |
- Bolsa de valores
- Insiders
- Julio Enrique Serrano Noguès